Bimatoprost
Overview
Bimatoprost is a prostaglandin analog used to treat certain types of glaucoma and ocular hypertension by reducing intraocular pressure. It also has cosmetic uses for promoting eyelash growth in individuals with hypotrichosis or inadequate eyelashes.
API suppliers (12)
Suppliers of Bimatoprost evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 11 of 12 suppliers.
6 of 12 hold a GMP certificate on record in the EU or UK registers
- CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
- EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
- INDUSTRIALE CHIMICA SRLItaly1 active DMF GMP on record
- CAYMAN PHARMA SROCzechia1 active DMF GMP on record
- YS LIFE SCIENCE CO LTD1 active DMF
- C-SQUARED PHARMA LTDUnited States1 active DMF
- Zhejiang Ausun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- EUROAPI HUNGARY LTDHungary1 active DMF
- FDC LimitedIndia1 active DMF GMP on record
- NEWCHEM SPAItaly1 active DMF GMP on record
- Lupin LimitedIndia GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (15 approved US products), the latest listed US patent on Bimatoprost expires 8 Jun 2036 and exclusivity 9 Sept 2028. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Bimatoprost? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.